Persisting molecular remission ten years after donor lymphocyte infusion for hematologic relapse in chronic myeloid leukemia
Mattei, D.; Saglio, G.; Gottardi, E.; Gallamini, A.; Mordini, N.; Bacigalupo, A.
Haematologica 86(5): 545-546
2001
ISSN/ISBN: 0390-6078 PMID: 11410423 Document Number: 529194
Document emailed within 1 workday
Related Documents
Gómez, M.; Urbano-Ispizua, A.; Cervantes, F.; Fernández-Avilés, F.; Rovira, M.; Carreras, E. 2002: Late response to donor lymphocyte infusions in patients with chronic myeloid leukemia relapsing after allogeneic stem cell transplantation Haematologica 87(9): 1003-1005Casado, L.F.; Picó, M.; Gómez, C.; Ferro, M.T.; Fernández-Rañada, J.M.; Steegmann, J.L. 1997: Fluctuating molecular remission in patients with chronic myeloid leukemia with long term complete cytogenetic response after alpha interferon treatment Medicina Clinica 109(7): 251-255
Drobyski, W.R.; Roth, M.S.; Thibodeau, S.N.; Gottschall, J.L. 1992: Molecular remission occurring after donor leukocyte infusions for the treatment of relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation Bone Marrow Transplantation 10(3): 301-304
Lönnqvist, B.; Brune, M.; Ljungman, P. 1996: Lymphoblastoid human interferon and low dose IL-2 combined with donor lymphocyte infusion as therapy of a third relapse of CML--a case report Bone Marrow Transplantation 18(1): 241-242
Lo Coco, F.; Mandelli, F.; Diverio, D.; Alimena, G.; De Fabritiis, P.; Meloni, G.; Cedrone, M.; Frontani, M.; Guerrasio, A.; Saglio, G. 1990: Therapy-induced Ph1 suppression in chronic myeloid leukemia: molecular and cytogenetic studies in patients treated with alpha-2b IFN, high-dose chemotherapy and autologous stem cell infusion Bone Marrow Transplantation 6(4): 253-258
Spinelli, O.; Giussani, U.; Borleri, G.; Lazzari, M.; Michelato, A.; Dotti, G.; Barbui, T.; Rambaldi, A. 2000: Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation Haematologica 85(11): 1153-1157
Luciano, L.; Catalano, L.; Sarrantonio, C.; Guerriero, A.; Califano, C.; Rotoli, B. 1999: AlphaIFN-induced hematologic and cytogenetic remission in chronic eosinophilic leukemia with t(1;5) Haematologica 84(7): 651-653
Takami, A.; Chuhjo, T.; Nakao, S. 2002: Relapse of chronic myeloid leukemia (CML) in lymphoid crisis after allogeneic bone marrow transplantation for CML in chronic phase with busulfan plus cyclophosphamide regimen Haematologica 87(6): 659-661
Jentsch-Ullrich, K.; Pelz, A-Friederike.; Braun, H.; Koenigsmann, M.; Mohren, M.; Wieacker, P.; Franke, A. 2004: Complete molecular remission in a patient with Philadelphia-chromosome positive acute myeloid leukemia after conventional therapy and imatinib Haematologica 89(5): Ecr15
Ferrara, F.; Martino, A.; Matera, C.; Prossomariti, L.; Rametta, V.; Ronconi, F.; Montuori, R. 1987: Chronic myeloid leukemia in childhood. Clinico-hematologic study of 40 cases Minerva Pediatrica 39(1-2): 15-18
Björkholm, M.; Holm, G.; Mellstedt, H. 1977: Persisting lymphocyte deficiences during remission in Hodgkin's disease Clinical and Experimental Immunology 28(3): 389-393
Du, B.; Li, D-peng.; Xu, K-lin.; Pan, X-ying. 2005: Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice Chinese Medical Journal 118(6): 474-479
2007: E2902: A Phase III randomized study of farnesyl transferase inhibitor R115777 in acute myeloid leukemia patients in second or subsequent remission or in remission after primary induction failure or patients over age 60 in first remission Clinical Advances in Hematology and Oncology: H&o 5(1): 13-14
Kiersnowska-Rogowska, B.; Parfieńczyk, A.; Rogowski, F. 2004: Blood levels of the adhesion molecules ICAM-1 and VCAM-1 in patients with chronic myeloid leukemia during remission and exacerbation Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 16(93): 240-244
Sasaki, K.; Mitani, K. 2009: Molecular pathogenesis of chronic myeloid leukemia Nihon Rinsho. Japanese Journal of Clinical Medicine 67(10): 1894-1899
Cervantes, F. 1993: Molecular biology studies in chronic myeloid leukemia Medicina Clinica 101(14): 538-540
Kajtár, B.él.; Méhes, G.áb.; Jaksó, P.ál.; Kereskai, L.ás.ó; Iványi, J.án.L.ás.ó; Losonczy, H.; Egyed, M.ós.; Tóth, P.ét.; Tóth, A.; Gasztonyi, Z.án.; Dömötör, M.ár.; Pajor, L.ás.ó 2006: Cytogenetic and molecular monitoring of chronic myeloid leukemia Orvosi Hetilap 147(21): 963-970
Jadayel, D.; Calabrese, G.; Min, T.; van Rhee, F.; Swansbury, G.J.; Dyer, M.J.; Maitland, J.; Palka, G.; Catovsky, D. 1995: Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation Leukemia 9(6): 981-987
Michalová, K.; Zemanová, Z.; Haskovec, C.; Rypácková, B.; Brdicka, R. 1992: Use of cytogenetic and molecular biology in the detection of chronic myeloid leukemia Casopis Lekaru Ceskych 131(24-25): 729-732
Piccaluga, P.Paolo.; Martinelli, G.; Malagola, M.; Rondoni, M.; Bianchini, M.; Visani, G.; Baccarani, M. 2003: Complete remission in acute myeloid leukemia with granulocyte-colony stimulating factor without chemotherapy. Report of cytogenetic remission of a t(9;11)(p22q23) positive AML patient and review of literature Haematologica 88(8): Ecr28